NURECA

Nureca Share Price

 

Stock Hit Upper Circuit

 

Start SIP in NURECA

Start SIP

Performance

  • Low
  • ₹282
  • High
  • ₹299
  • 52 Week Low
  • ₹204
  • 52 Week High
  • ₹448
  • Open Price₹284
  • Previous Close₹285
  • Volume28,335

Investment Returns

  • Over 1 Month + 13.83%
  • Over 3 Month + 23.07%
  • Over 6 Month + 1.01%
  • Over 1 Year + 2.65%

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 69.4
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 285
  • P/B Ratio
  • 1.4
  • Average True Range
  • 11.48
  • EPS
  • 4.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.92
  • RSI
  • 49.89
  • MFI
  • 35.24

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹284.85
+ 0.1 (0.04%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹286.55
  • 50 Day
  • ₹278.80
  • 100 Day
  • ₹270.73
  • 200 Day
  • ₹269.36

Resistance and Support

288.7 Pivot Speed
  • R3 311.75
  • R2 305.35
  • R1 295.10
  • S1 278.45
  • S2 272.05
  • S3 261.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 130.12 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 16% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 114 indicates it belongs to a poor industry group of Medical-Products and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-28 Buy Back of Shares
2025-11-10 Buy Back of Shares
2025-10-16 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-07-15 Quarterly Results
2025-05-05 Audited Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Nureca Dividend History Arrow

Nureca F&O

Nureca Shareholding Pattern

64.97%
0%
0%
0.07%
0%
32.15%
2.81%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹284 As on 27 December, 2025 | 01:59

The Market Cap of Nureca is ₹284.9 Cr As on 27 December, 2025 | 01:59

The P/E ratio of Nureca is 69.4 As on 27 December, 2025 | 01:59

The PB ratio of Nureca is 1.4 As on 27 December, 2025 | 01:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23